135 related articles for article (PubMed ID: 2482572)
1. Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas. An immunohistochemical study using monoclonal antibody AE14.
Moll R; Dhouailly D; Sun TT
Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 58(2):129-45. PubMed ID: 2482572
[TBL] [Abstract][Full Text] [Related]
2. Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach.
Battifora H; Kopinski MI
Cancer; 1985 Apr; 55(8):1679-85. PubMed ID: 2579718
[TBL] [Abstract][Full Text] [Related]
3. Distinct keratin patterns demonstrated by immunoperoxidase staining of adenocarcinomas, carcinoids, and mesotheliomas using polyclonal and monoclonal anti-keratin antibodies.
Kahn HJ; Thorner PS; Yeger H; Bailey D; Baumal R
Am J Clin Pathol; 1986 Nov; 86(5):566-74. PubMed ID: 2430449
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors. Use in surgical pathology.
Ramaekers F; Huysmans A; Moesker O; Kant A; Jap P; Herman C; Vooijs P
Lab Invest; 1983 Sep; 49(3):353-61. PubMed ID: 6193333
[TBL] [Abstract][Full Text] [Related]
5. Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12.
Lee I; Radosevich JA; Chejfec G; Ma YX; Warren WH; Rosen ST; Gould VE
Am J Pathol; 1986 Jun; 123(3):497-507. PubMed ID: 3717302
[TBL] [Abstract][Full Text] [Related]
6. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma.
Ordóñez NG
Am J Surg Pathol; 1998 Oct; 22(10):1215-21. PubMed ID: 9777983
[TBL] [Abstract][Full Text] [Related]
7. Keratins in malignant mesotheliomas and pleural adenocarcinomas: comparative immunohistochemical analysis with polyclonal and monoclonal antibodies.
Bejui-Thivolet F; Patricot LM; Vauzelle JL; Viac J
Pathol Res Pract; 1984 Sep; 179(1):67-73. PubMed ID: 6209691
[TBL] [Abstract][Full Text] [Related]
8. Keratin and carcinoembryonic antigen in exfoliated mesothelial and malignant cells: an immunoperoxidase study.
Walts AE; Said JW; Banks-Schlegel S
Am J Clin Pathol; 1983 Nov; 80(5):671-6. PubMed ID: 6195913
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical staining for vimentin and keratin in malignant mesothelioma.
Churg A
Am J Surg Pathol; 1985 May; 9(5):360-5. PubMed ID: 2418692
[TBL] [Abstract][Full Text] [Related]
10. Value of mesothelin immunostaining in the diagnosis of mesothelioma.
Ordóñez NG
Mod Pathol; 2003 Mar; 16(3):192-7. PubMed ID: 12640097
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma.
Holden J; Churg A
Am J Surg Pathol; 1984 Apr; 8(4):277-9. PubMed ID: 6201076
[TBL] [Abstract][Full Text] [Related]
12. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas.
Tot T
Cancer; 2001 Nov; 92(10):2727-32. PubMed ID: 11745209
[TBL] [Abstract][Full Text] [Related]
13. [Malignant mesothelioma of the pleura. Analysis of its immunohistochemical aspects].
Chenard-Neu MP; Bellocq JP; Maier A; Batzenschlager A
Ann Pathol; 1990; 10(1):20-7. PubMed ID: 2328062
[TBL] [Abstract][Full Text] [Related]
14. The limited difference between keratin patterns of squamous cell carcinomas and adenocarcinomas is explicable by both cell lineage and state of differentiation of tumour cells.
van Dorst EB; van Muijen GN; Litvinov SV; Fleuren GJ
J Clin Pathol; 1998 Sep; 51(9):679-84. PubMed ID: 9930073
[TBL] [Abstract][Full Text] [Related]
15. Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature.
Ordóñez NG
Am J Clin Pathol; 1998 Jan; 109(1):85-9. PubMed ID: 9426522
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical distinction of malignant mesothelioma from pulmonary adenocarcinoma with anti-surfactant apoprotein, anti-Lewisa, and anti-Tn antibodies.
Noguchi M; Nakajima T; Hirohashi S; Akiba T; Shimosato Y
Hum Pathol; 1989 Jan; 20(1):53-7. PubMed ID: 2912874
[TBL] [Abstract][Full Text] [Related]
17. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas.
Ramaekers F; van Niekerk C; Poels L; Schaafsma E; Huijsmans A; Robben H; Schaart G; Vooijs P
Am J Pathol; 1990 Mar; 136(3):641-55. PubMed ID: 1690512
[TBL] [Abstract][Full Text] [Related]
18. Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas.
Corson JM; Pinkus GS
Am J Pathol; 1982 Jul; 108(1):80-8. PubMed ID: 6178295
[TBL] [Abstract][Full Text] [Related]
19. Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma.
Miettinen M; Limon J; Niezabitowski A; Lasota J
Am J Surg Pathol; 2001 May; 25(5):610-7. PubMed ID: 11342772
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous immunoenzyme staining of vimentin and cytokeratins with monoclonal antibodies as an aid in the differential diagnosis of malignant mesothelioma from pulmonary adenocarcinoma.
Mullink H; Henzen-Logmans SC; Alons-van Kordelaar JJ; Tadema TM; Meijer CJ
Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(1):55-65. PubMed ID: 2435052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
